S E C U R I T I E S A N D E X C H A N G E
C O M M I S S I O N
Washington, D.C. 20549
R E P O R T O N F O R M 10-K/A-1
FIRST AMENDED ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For fiscal year ended December 28, l997
Commission file number 0-14887
T H E L I P O S O M E C O M P A N Y, I N C.
(Exact name of registrant as specified in its charter)
Delaware 22-2370691
(State or other jurisdiction of (IRS Employer
incorporation or organization) Identification No.)
One Research Way, Princeton Forrestal Center, Princeton,
New Jersey 08540
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code:
(609) 452-7060
Securities registered pursuant to Section 12(b) of the Act:
None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.0l Par Value;
Depositary Shares each representing 1/10 of a share of
Registrant's Series A
Cumulative Convertible Exchangeable Preferred Stock;
Series A Cumulative Convertible Exchangeable Preferred
Stock, $.01 Par Value
(Title of Class)
PART II
Item 5. Market for Registrant's Common Equity and Related
Stockholder Matters
(a) Market Information
The Company's Common Stock is traded on the Nasdaq
National Market System under the symbol LIPO. The following
table sets forth for the periods indicated the high and low
sale price for the Common Stock:
High Low
1997
4th Quarter $7.3750 $4.0000
3rd Quarter 9.1250 6.3750
2nd Quarter 28.250 7.6250
1st Quarter 29.500 17.875
High Low
1996
4th Quarter $22.750 $14.875
3rd Quarter 19.875 11.875
2nd Quarter 26.125 16.000
1st Quarter 25.125 16.250
(b) Holders
At February 25, 1998, there were approximately 1,050
stockholders of record of the Company's Common Stock.
(c) Dividends
The Company has not paid any cash dividends on its Common
Stock since its inception and does not anticipate paying any
cash dividends on its Common Stock in the foreseeable
future. The declaration and payment of Common Stock
dividends, if any, is within the discretion of the Board of
Directors and will depend, among other things, upon future
earnings, the operating and financial condition of the
Company, its capital requirements, and general business
conditions.
SIGNATURES
Pursuant to the requirements of Section 13 of the
Securities Exchange Act of 1934, the Registrant has duly
caused this amended report to be signed on its behalf by the
undersigned thereunto duly authorized this 7th day of April,
1998.
THE LIPOSOME COMPANY, INC.
AND SUBSIDIARIES
By: /s/Charles A. Baker
Charles A. Baker
Chairman of the Board,
President,
Chief Executive Officer,
and Director
